Copyright Reports & Markets. All rights reserved.

Global Tissue Engineering-based Regeneration Products Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Tissue Engineering-based Regeneration Products Market Size 2017-2028
    • 2.1.2 Tissue Engineering-based Regeneration Products Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Tissue Engineering-based Regeneration Products Segment by Type
    • 2.2.1 Allografts
    • 2.2.2 Autografts
    • 2.2.3 Xenografts
  • 2.3 Tissue Engineering-based Regeneration Products Market Size by Type
    • 2.3.1 Tissue Engineering-based Regeneration Products Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Tissue Engineering-based Regeneration Products Market Size Market Share by Type (2017-2022)
  • 2.4 Tissue Engineering-based Regeneration Products Segment by Application
    • 2.4.1 Bone Healing
    • 2.4.2 Burn Healing
    • 2.4.3 Wound Healing
    • 2.4.4 Others
  • 2.5 Tissue Engineering-based Regeneration Products Market Size by Application
    • 2.5.1 Tissue Engineering-based Regeneration Products Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Tissue Engineering-based Regeneration Products Market Size Market Share by Application (2017-2022)

3 Tissue Engineering-based Regeneration Products Market Size by Player

  • 3.1 Tissue Engineering-based Regeneration Products Market Size Market Share by Players
    • 3.1.1 Global Tissue Engineering-based Regeneration Products Revenue by Players (2020-2022)
    • 3.1.2 Global Tissue Engineering-based Regeneration Products Revenue Market Share by Players (2020-2022)
  • 3.2 Global Tissue Engineering-based Regeneration Products Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Tissue Engineering-based Regeneration Products by Regions

  • 4.1 Tissue Engineering-based Regeneration Products Market Size by Regions (2017-2022)
  • 4.2 Americas Tissue Engineering-based Regeneration Products Market Size Growth (2017-2022)
  • 4.3 APAC Tissue Engineering-based Regeneration Products Market Size Growth (2017-2022)
  • 4.4 Europe Tissue Engineering-based Regeneration Products Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Tissue Engineering-based Regeneration Products Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Tissue Engineering-based Regeneration Products Market Size by Country (2017-2022)
  • 5.2 Americas Tissue Engineering-based Regeneration Products Market Size by Type (2017-2022)
  • 5.3 Americas Tissue Engineering-based Regeneration Products Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Tissue Engineering-based Regeneration Products Market Size by Region (2017-2022)
  • 6.2 APAC Tissue Engineering-based Regeneration Products Market Size by Type (2017-2022)
  • 6.3 APAC Tissue Engineering-based Regeneration Products Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Tissue Engineering-based Regeneration Products by Country (2017-2022)
  • 7.2 Europe Tissue Engineering-based Regeneration Products Market Size by Type (2017-2022)
  • 7.3 Europe Tissue Engineering-based Regeneration Products Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Tissue Engineering-based Regeneration Products by Region (2017-2022)
  • 8.2 Middle East & Africa Tissue Engineering-based Regeneration Products Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Tissue Engineering-based Regeneration Products Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Tissue Engineering-based Regeneration Products Market Forecast

  • 10.1 Global Tissue Engineering-based Regeneration Products Forecast by Regions (2023-2028)
    • 10.1.1 Global Tissue Engineering-based Regeneration Products Forecast by Regions (2023-2028)
    • 10.1.2 Americas Tissue Engineering-based Regeneration Products Forecast
    • 10.1.3 APAC Tissue Engineering-based Regeneration Products Forecast
    • 10.1.4 Europe Tissue Engineering-based Regeneration Products Forecast
    • 10.1.5 Middle East & Africa Tissue Engineering-based Regeneration Products Forecast
  • 10.2 Americas Tissue Engineering-based Regeneration Products Forecast by Country (2023-2028)
    • 10.2.1 United States Tissue Engineering-based Regeneration Products Market Forecast
    • 10.2.2 Canada Tissue Engineering-based Regeneration Products Market Forecast
    • 10.2.3 Mexico Tissue Engineering-based Regeneration Products Market Forecast
    • 10.2.4 Brazil Tissue Engineering-based Regeneration Products Market Forecast
  • 10.3 APAC Tissue Engineering-based Regeneration Products Forecast by Region (2023-2028)
    • 10.3.1 China Tissue Engineering-based Regeneration Products Market Forecast
    • 10.3.2 Japan Tissue Engineering-based Regeneration Products Market Forecast
    • 10.3.3 Korea Tissue Engineering-based Regeneration Products Market Forecast
    • 10.3.4 Southeast Asia Tissue Engineering-based Regeneration Products Market Forecast
    • 10.3.5 India Tissue Engineering-based Regeneration Products Market Forecast
    • 10.3.6 Australia Tissue Engineering-based Regeneration Products Market Forecast
  • 10.4 Europe Tissue Engineering-based Regeneration Products Forecast by Country (2023-2028)
    • 10.4.1 Germany Tissue Engineering-based Regeneration Products Market Forecast
    • 10.4.2 France Tissue Engineering-based Regeneration Products Market Forecast
    • 10.4.3 UK Tissue Engineering-based Regeneration Products Market Forecast
    • 10.4.4 Italy Tissue Engineering-based Regeneration Products Market Forecast
    • 10.4.5 Russia Tissue Engineering-based Regeneration Products Market Forecast
  • 10.5 Middle East & Africa Tissue Engineering-based Regeneration Products Forecast by Region (2023-2028)
    • 10.5.1 Egypt Tissue Engineering-based Regeneration Products Market Forecast
    • 10.5.2 South Africa Tissue Engineering-based Regeneration Products Market Forecast
    • 10.5.3 Israel Tissue Engineering-based Regeneration Products Market Forecast
    • 10.5.4 Turkey Tissue Engineering-based Regeneration Products Market Forecast
    • 10.5.5 GCC Countries Tissue Engineering-based Regeneration Products Market Forecast
  • 10.6 Global Tissue Engineering-based Regeneration Products Forecast by Type (2023-2028)
  • 10.7 Global Tissue Engineering-based Regeneration Products Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 AlloSource
    • 11.1.1 AlloSource Company Information
    • 11.1.2 AlloSource Tissue Engineering-based Regeneration Products Product Offered
    • 11.1.3 AlloSource Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 AlloSource Main Business Overview
    • 11.1.5 AlloSource Latest Developments
  • 11.2 BioTissue
    • 11.2.1 BioTissue Company Information
    • 11.2.2 BioTissue Tissue Engineering-based Regeneration Products Product Offered
    • 11.2.3 BioTissue Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 BioTissue Main Business Overview
    • 11.2.5 BioTissue Latest Developments
  • 11.3 Integra Lifesciences Corporation
    • 11.3.1 Integra Lifesciences Corporation Company Information
    • 11.3.2 Integra Lifesciences Corporation Tissue Engineering-based Regeneration Products Product Offered
    • 11.3.3 Integra Lifesciences Corporation Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Integra Lifesciences Corporation Main Business Overview
    • 11.3.5 Integra Lifesciences Corporation Latest Developments
  • 11.4 MiMedx
    • 11.4.1 MiMedx Company Information
    • 11.4.2 MiMedx Tissue Engineering-based Regeneration Products Product Offered
    • 11.4.3 MiMedx Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 MiMedx Main Business Overview
    • 11.4.5 MiMedx Latest Developments
  • 11.5 Organogenesis, Inc.
    • 11.5.1 Organogenesis, Inc. Company Information
    • 11.5.2 Organogenesis, Inc. Tissue Engineering-based Regeneration Products Product Offered
    • 11.5.3 Organogenesis, Inc. Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Organogenesis, Inc. Main Business Overview
    • 11.5.5 Organogenesis, Inc. Latest Developments
  • 11.6 Smith +Nephew
    • 11.6.1 Smith +Nephew Company Information
    • 11.6.2 Smith +Nephew Tissue Engineering-based Regeneration Products Product Offered
    • 11.6.3 Smith +Nephew Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Smith +Nephew Main Business Overview
    • 11.6.5 Smith +Nephew Latest Developments
  • 11.7 Tissue Regenix
    • 11.7.1 Tissue Regenix Company Information
    • 11.7.2 Tissue Regenix Tissue Engineering-based Regeneration Products Product Offered
    • 11.7.3 Tissue Regenix Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Tissue Regenix Main Business Overview
    • 11.7.5 Tissue Regenix Latest Developments
  • 11.8 VIVEX Biologics
    • 11.8.1 VIVEX Biologics Company Information
    • 11.8.2 VIVEX Biologics Tissue Engineering-based Regeneration Products Product Offered
    • 11.8.3 VIVEX Biologics Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 VIVEX Biologics Main Business Overview
    • 11.8.5 VIVEX Biologics Latest Developments
  • 11.9 Alliqua BioMedical, Inc.
    • 11.9.1 Alliqua BioMedical, Inc. Company Information
    • 11.9.2 Alliqua BioMedical, Inc. Tissue Engineering-based Regeneration Products Product Offered
    • 11.9.3 Alliqua BioMedical, Inc. Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Alliqua BioMedical, Inc. Main Business Overview
    • 11.9.5 Alliqua BioMedical, Inc. Latest Developments
  • 11.10 MISONIX, Inc.
    • 11.10.1 MISONIX, Inc. Company Information
    • 11.10.2 MISONIX, Inc. Tissue Engineering-based Regeneration Products Product Offered
    • 11.10.3 MISONIX, Inc. Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 MISONIX, Inc. Main Business Overview
    • 11.10.5 MISONIX, Inc. Latest Developments
  • 11.11 Arthrex, Inc.
    • 11.11.1 Arthrex, Inc. Company Information
    • 11.11.2 Arthrex, Inc. Tissue Engineering-based Regeneration Products Product Offered
    • 11.11.3 Arthrex, Inc. Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Arthrex, Inc. Main Business Overview
    • 11.11.5 Arthrex, Inc. Latest Developments
  • 11.12 Braun Melsungen AG
    • 11.12.1 Braun Melsungen AG Company Information
    • 11.12.2 Braun Melsungen AG Tissue Engineering-based Regeneration Products Product Offered
    • 11.12.3 Braun Melsungen AG Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Braun Melsungen AG Main Business Overview
    • 11.12.5 Braun Melsungen AG Latest Developments
  • 11.13 BARD, A Becton, Dickinson Company
    • 11.13.1 BARD, A Becton, Dickinson Company Company Information
    • 11.13.2 BARD, A Becton, Dickinson Company Tissue Engineering-based Regeneration Products Product Offered
    • 11.13.3 BARD, A Becton, Dickinson Company Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 BARD, A Becton, Dickinson Company Main Business Overview
    • 11.13.5 BARD, A Becton, Dickinson Company Latest Developments
  • 11.14 ConMed Corporation
    • 11.14.1 ConMed Corporation Company Information
    • 11.14.2 ConMed Corporation Tissue Engineering-based Regeneration Products Product Offered
    • 11.14.3 ConMed Corporation Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 ConMed Corporation Main Business Overview
    • 11.14.5 ConMed Corporation Latest Developments
  • 11.15 Globus Medical, Inc.
    • 11.15.1 Globus Medical, Inc. Company Information
    • 11.15.2 Globus Medical, Inc. Tissue Engineering-based Regeneration Products Product Offered
    • 11.15.3 Globus Medical, Inc. Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 Globus Medical, Inc. Main Business Overview
    • 11.15.5 Globus Medical, Inc. Latest Developments
  • 11.16 Lattice Biologics Ltd.
    • 11.16.1 Lattice Biologics Ltd. Company Information
    • 11.16.2 Lattice Biologics Ltd. Tissue Engineering-based Regeneration Products Product Offered
    • 11.16.3 Lattice Biologics Ltd. Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.16.4 Lattice Biologics Ltd. Main Business Overview
    • 11.16.5 Lattice Biologics Ltd. Latest Developments
  • 11.17 Osiris Therapeutics, Inc.
    • 11.17.1 Osiris Therapeutics, Inc. Company Information
    • 11.17.2 Osiris Therapeutics, Inc. Tissue Engineering-based Regeneration Products Product Offered
    • 11.17.3 Osiris Therapeutics, Inc. Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.17.4 Osiris Therapeutics, Inc. Main Business Overview
    • 11.17.5 Osiris Therapeutics, Inc. Latest Developments
  • 11.18 Straumann
    • 11.18.1 Straumann Company Information
    • 11.18.2 Straumann Tissue Engineering-based Regeneration Products Product Offered
    • 11.18.3 Straumann Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.18.4 Straumann Main Business Overview
    • 11.18.5 Straumann Latest Developments
  • 11.19 Xtant Medical
    • 11.19.1 Xtant Medical Company Information
    • 11.19.2 Xtant Medical Tissue Engineering-based Regeneration Products Product Offered
    • 11.19.3 Xtant Medical Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.19.4 Xtant Medical Main Business Overview
    • 11.19.5 Xtant Medical Latest Developments
  • 11.20 Zimmer Biomet Holdings, Inc.
    • 11.20.1 Zimmer Biomet Holdings, Inc. Company Information
    • 11.20.2 Zimmer Biomet Holdings, Inc. Tissue Engineering-based Regeneration Products Product Offered
    • 11.20.3 Zimmer Biomet Holdings, Inc. Tissue Engineering-based Regeneration Products Revenue, Gross Margin and Market Share (2020-2022)
    • 11.20.4 Zimmer Biomet Holdings, Inc. Main Business Overview
    • 11.20.5 Zimmer Biomet Holdings, Inc. Latest Developments

12 Research Findings and Conclusion

The global market for Tissue Engineering-based Regeneration Products is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Tissue Engineering-based Regeneration Products market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Tissue Engineering-based Regeneration Products market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Tissue Engineering-based Regeneration Products market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Tissue Engineering-based Regeneration Products market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Tissue Engineering-based Regeneration Products players cover AlloSource, BioTissue, Integra Lifesciences Corporation, MiMedx and Organogenesis, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Tissue Engineering-based Regeneration Products market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Tissue Engineering-based Regeneration Products market, with both quantitative and qualitative data, to help readers understand how the Tissue Engineering-based Regeneration Products market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Tissue Engineering-based Regeneration Products market and forecasts the market size by Type (Allografts, Autografts and Xenografts), by Application (Bone Healing, Burn Healing, Wound Healing and Others), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Allografts
Autografts
Xenografts

Segmentation by application
Bone Healing
Burn Healing
Wound Healing
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
AlloSource
BioTissue
Integra Lifesciences Corporation
MiMedx
Organogenesis, Inc.
Smith +Nephew
Tissue Regenix
VIVEX Biologics
Alliqua BioMedical, Inc.
MISONIX, Inc.
Arthrex, Inc.
Braun Melsungen AG
BARD, A Becton, Dickinson Company
ConMed Corporation
Globus Medical, Inc.
Lattice Biologics Ltd.
Osiris Therapeutics, Inc.
Straumann
Xtant Medical
Zimmer Biomet Holdings, Inc.

Chapter Introduction
Chapter 1: Scope of Tissue Engineering-based Regeneration Products, Research Methodology, etc.
Chapter 2: Executive Summary, global Tissue Engineering-based Regeneration Products market size and CAGR, Tissue Engineering-based Regeneration Products market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Tissue Engineering-based Regeneration Products revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Tissue Engineering-based Regeneration Products revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Tissue Engineering-based Regeneration Products market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including AlloSource, BioTissue, Integra Lifesciences Corporation, MiMedx, Organogenesis, Inc., Smith +Nephew, Tissue Regenix, VIVEX Biologics and Alliqua BioMedical, Inc., etc.
Chapter 14: Research Findings and Conclusion
Buy now